メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Bluebird bio, Inc.
Acceleron Pharma, Inc.
Celgene Corporation
GlaxoSmithKline plc
Incyte Corporation
Gamida Cell
Kiadis Pharma
La Jolla Pharmaceutical Company
IONIS Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Thalassemia Market Size Growth Rate by Type (2015-2028)
1.4.2 Iron Chelating Drugs
1.4.3 Others
1.5 Market by Application
1.5.1 Global Thalassemia Market Share by Application (2015-2028)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Institute
1.5.5 Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Thalassemia Market Size
2.2 Thalassemia Growth Trends by Regions
2.2.1 Thalassemia Market Size by Regions (2015-2028)
2.2.2 Thalassemia Market Share by Regions (2015-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Thalassemia Market Size by Manufacturers
3.1.1 Global Thalassemia Revenue by Manufacturers (2015-2020)
3.1.2 Global Thalassemia Revenue Market Share by Manufacturers (2015-2020)
3.1.3 Global Thalassemia Market Concentration Ratio (CR5 and HHI)
3.2 Thalassemia Key Players Head office and Area Served
3.3 Key Players Thalassemia Product/Solution/Service
3.4 Date of Enter into Thalassemia Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Thalassemia Market Size by Type (2015-2020)
4.2 Global Thalassemia Market Size by Application (2015-2020)
5 United States
5.1 United States Thalassemia Market Size (2015-2020)
5.2 Thalassemia Key Players in United States
5.3 United States Thalassemia Market Size by Type
5.4 United States Thalassemia Market Size by Application
6 Europe
6.1 Europe Thalassemia Market Size (2015-2020)
6.2 Thalassemia Key Players in Europe
6.3 Europe Thalassemia Market Size by Type
6.4 Europe Thalassemia Market Size by Application
7 China
7.1 China Thalassemia Market Size (2015-2020)
7.2 Thalassemia Key Players in China
7.3 China Thalassemia Market Size by Type
7.4 China Thalassemia Market Size by Application
8 Japan
8.1 Japan Thalassemia Market Size (2015-2020)
8.2 Thalassemia Key Players in Japan
8.3 Japan Thalassemia Market Size by Type
8.4 Japan Thalassemia Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Thalassemia Market Size (2015-2020)
9.2 Thalassemia Key Players in Southeast Asia
9.3 Southeast Asia Thalassemia Market Size by Type
9.4 Southeast Asia Thalassemia Market Size by Application
10 India
10.1 India Thalassemia Market Size (2015-2020)
10.2 Thalassemia Key Players in India
10.3 India Thalassemia Market Size by Type
10.4 India Thalassemia Market Size by Application
11 Central & South America
11.1 Central & South America Thalassemia Market Size (2015-2020)
11.2 Thalassemia Key Players in Central & South America
11.3 Central & South America Thalassemia Market Size by Type
11.4 Central & South America Thalassemia Market Size by Application
12 International Players Profiles
12.1 Bluebird bio, Inc.
12.1.1 Bluebird bio, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Thalassemia Introduction
12.1.4 Bluebird bio, Inc. Revenue in Thalassemia Business (2015-2020)
12.1.5 Bluebird bio, Inc. Recent Development
12.2 Acceleron Pharma, Inc.
12.2.1 Acceleron Pharma, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Thalassemia Introduction
12.2.4 Acceleron Pharma, Inc. Revenue in Thalassemia Business (2015-2020)
12.2.5 Acceleron Pharma, Inc. Recent Development
12.3 Celgene Corporation
12.3.1 Celgene Corporation Company Details
12.3.2 Company Description and Business Overview
12.3.3 Thalassemia Introduction
12.3.4 Celgene Corporation Revenue in Thalassemia Business (2015-2020)
12.3.5 Celgene Corporation Recent Development
12.4 GlaxoSmithKline plc
12.4.1 GlaxoSmithKline plc Company Details
12.4.2 Company Description and Business Overview
12.4.3 Thalassemia Introduction
12.4.4 GlaxoSmithKline plc Revenue in Thalassemia Business (2015-2020)
12.4.5 GlaxoSmithKline plc Recent Development
12.5 Incyte Corporation
12.5.1 Incyte Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Thalassemia Introduction
12.5.4 Incyte Corporation Revenue in Thalassemia Business (2015-2020)
12.5.5 Incyte Corporation Recent Development
12.6 Gamida Cell
12.6.1 Gamida Cell Company Details
12.6.2 Company Description and Business Overview
12.6.3 Thalassemia Introduction
12.6.4 Gamida Cell Revenue in Thalassemia Business (2015-2020)
12.6.5 Gamida Cell Recent Development
12.7 Kiadis Pharma
12.7.1 Kiadis Pharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Thalassemia Introduction
12.7.4 Kiadis Pharma Revenue in Thalassemia Business (2015-2020)
12.7.5 Kiadis Pharma Recent Development
12.8 La Jolla Pharmaceutical Company
12.8.1 La Jolla Pharmaceutical Company Company Details
12.8.2 Company Description and Business Overview
12.8.3 Thalassemia Introduction
12.8.4 La Jolla Pharmaceutical Company Revenue in Thalassemia Business (2015-2020)
12.8.5 La Jolla Pharmaceutical Company Recent Development
12.9 IONIS Pharmaceuticals
12.9.1 IONIS Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Thalassemia Introduction
12.9.4 IONIS Pharmaceuticals Revenue in Thalassemia Business (2015-2020)
12.9.5 IONIS Pharmaceuticals Recent Development
13 Market Forecast 2021-2028
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2028)
13.10 Market Size Forecast by Application (2021-2028)
14 Analysts Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details